Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.35 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.34 |
| ▸ | ABAT | P80404 | 1/20 | 0.34 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.33 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2673169 | 0.74 | CYP2A6 (0.39) | CYP2A6ALDH1A1TYRCYP2A13HSD17B10 | |
| SCHEMBL4376737 | 0.74 | PNMT (0.45) | ALDH1A1 | |
| SCHEMBL13947217 | 0.73 | CYP2A6 (0.44) | CYP2A6ALDH1A1TYRCYP2A13HSD17B10 | |
| SCHEMBL3130144 | 0.73 | CYP2A6 (0.41) | CYP2A6ALDH1A1TYRCYP2A13HSD17B10 | |
| SCHEMBL27983894 | 0.70 | ALDH1A1 (0.44) | CYP2A6ALDH1A1TYRCYP2A13HSD17B10 | |
| SCHEMBL5177793 | 0.70 | CYP2A6 (0.46) | CYP2A6ALDH1A1TYRCYP2A13HSD17B10 | |
| SCHEMBL28948602 | 0.66 | ALDH1A1 (0.42) | CYP2A6ALDH1A1TYRCYP2A13HSD17B10 | |
| SCHEMBL8748149 | 0.66 | ALDH1A1 (0.42) | CYP2A6ALDH1A1TYRCYP2A13HSD17B10 | |
| SCHEMBL29087595 | 0.65 | CYP2A6 (0.41) | CYP2A6ALDH1A1TYRCYP2A13HSD17B10 | |
| SCHEMBL548601 | 0.65 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173630-B2 | Multipodal tethers for high-density attachment of redox-active moieties to substrates | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-05-08 | — | — | US | disclosed |
| US-20070108438-A1 | Multypodal tethers for high-density attachment of redox-active moieties to substrates | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070108438-A1 | Multypodal tethers for high-density attachment of redox-active moieties to substrates | DNMT1, TET1, SOD1 | CYP2A6 3333/4885ALDH1A1 77/4885TYR 2246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.